Mikaela Naylon Give Kids a Chance Act

This bill gives the Food and Drug Administration more power to oversee research on rare diseases that affect children. It allows the FDA to take action against drug companies that don't follow rules about studying how medicines work in kids. The bill also extends a program that gives special benefits to companies that develop treatments for rare childhood diseases until 2029, and continues funding for children's medical research through 2027. Additionally, it clarifies that when a drug gets special protection for treating a rare disease, other companies can't make the same drug for that same specific use for seven years.

Your Vote